Surgical Outcomes of Hugo™ RAS Robot-Assisted Partial Nephrectomy for Cystic Renal Masses: Technique and Initial Experience.
Francesco PrataAndrea IannuzziFrancesco TedescoAlberto RagusaAngelo CivitellaMatteo PiraMarco FantozziLeonilde SicaRoberto Mario ScarpaRocco PapaliaPublished in: Journal of clinical medicine (2024)
Background : The Hugo™ Robot-Assisted Surgery (RAS) system is a new cutting-edge robotic platform designed for clinical applications. Nevertheless, its application for cystic renal tumors has not yet been thoroughly investigated. In this context, we present an initial series of Robot-Assisted Partial Nephrectomy (RAPN) procedures carried out using the Hugo™ RAS system for cystic renal masses. Methods : Between October 2022 and January 2024, twenty-seven RAPN procedures for renal tumors were performed at Fondazione Policlinico Universitario Campus Bio-Medico. Our prospective board-approved dataset was queried for "cystic features" (n = 12). Perioperative data were collected. The eGFR was calculated according to the CKD-EPI formula. Post-operative complications were reported according to the Clavien-Dindo classification. Computed tomography (CT) scans for follow-up were performed according to the EAU guidelines. Trifecta was defined as the coexistence of negative surgical margin status, no Clavien-Dindo grade ≥ 3 complications, and eGFR decline ≤ 30%. Results : All the patients successfully underwent RAPN without the need for conversion or additional port placement. The median docking and console time were 5.5 (IQR, 4-6) and 79.5 min (IQR, 58-91 min), respectively. No intraoperative complications occurred, as well as clashes between instruments or with the bedside assistant. Two minor postoperative complications were recorded (Clavien-Dindo II). At discharge, serum creatinine and eGFR were comparable to preoperative values. Only one patient (8.4%) displayed positive surgical margins. The rate of trifecta achievement was 91.7%. Conclusions : RAPN for cystic renal masses using the novel Hugo™ RAS system can be safely and effectively performed. This robotic system provided satisfactory peri-operative outcomes, preserving renal function and displaying low postoperative complications and a high trifecta rate achievement.
Keyphrases
- robot assisted
- minimally invasive
- computed tomography
- small cell lung cancer
- contrast enhanced
- epidermal growth factor receptor
- tyrosine kinase
- magnetic resonance imaging
- patients undergoing
- positron emission tomography
- wild type
- dual energy
- ultrasound guided
- chronic kidney disease
- newly diagnosed
- patient reported outcomes
- molecular dynamics
- type diabetes
- magnetic resonance
- metabolic syndrome
- case report
- image quality
- prognostic factors
- skeletal muscle
- percutaneous coronary intervention
- clinical practice
- small molecule
- big data
- coronary artery bypass
- electronic health record
- artificial intelligence
- surgical site infection
- single cell